ArticleFrontiers in pharmacology2020

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial.

Wei Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.